328 related articles for article (PubMed ID: 19178408)
1. Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis.
Nedoszytko B; Niedoszytko M; Lange M; van Doormaal J; Gleń J; Zabłotna M; Renke J; Vales A; Buljubasic F; Jassem E; Roszkiewicz J; Valent P
Allergy; 2009 Feb; 64(2):287-94. PubMed ID: 19178408
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of interleukin-13 gene - 1112c/T polymorphism with asthma and total plasma IgE levels].
Wu B; Liu JL; Chen M; Deng RQ; Wu D
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):668-71. PubMed ID: 16200868
[TBL] [Abstract][Full Text] [Related]
3. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
4. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults.
Kilpinen S; Hulkkonen J; Wang XY; Hurme M
Eur Cytokine Netw; 2001 Mar; 12(1):62-8. PubMed ID: 11282548
[TBL] [Abstract][Full Text] [Related]
5. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
6. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes.
Takahashi N; Akahoshi M; Matsuda A; Ebe K; Inomata N; Obara K; Hirota T; Nakashima K; Shimizu M; Tamari M; Doi S; Miyatake A; Enomoto T; Nakashima H; Ikezawa Z; Shirakawa T
Hum Mol Genet; 2005 Nov; 14(21):3149-59. PubMed ID: 16159888
[TBL] [Abstract][Full Text] [Related]
7. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.
Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811
[TBL] [Abstract][Full Text] [Related]
8. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
9. [Serum level and genotype of interleukin-6 in patients with esophageal cancer].
Tang RG; Wei YS; Chen HM; Fang WZ; Long XK; Yuan XH
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1126-8. PubMed ID: 17672997
[TBL] [Abstract][Full Text] [Related]
10. [The study of interleukin-13 gene promoter polymorphism in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Ning LD; Jiang L; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):529-32. PubMed ID: 15388001
[TBL] [Abstract][Full Text] [Related]
11. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
12. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
Fishman D; Faulds G; Jeffery R; Mohamed-Ali V; Yudkin JS; Humphries S; Woo P
J Clin Invest; 1998 Oct; 102(7):1369-76. PubMed ID: 9769329
[TBL] [Abstract][Full Text] [Related]
13. Association between the polymorphisms of IL-4 gene promoter (-590C>T), IL-13 coding region (R130Q) and IL-16 gene promoter (-295T>C) and allergic asthma.
Hosseini-Farahabadi S; Tavakkol-Afshari J; Rafatpanah H; Farid Hosseini R; Khaje Daluei M
Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):9-14. PubMed ID: 17303923
[TBL] [Abstract][Full Text] [Related]
14. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism.
van der Pouw Kraan TC; Küçükaycan M; Bakker AM; Baggen JM; van der Zee JS; Dentener MA; Wouters EF; Verweij CL
Genes Immun; 2002 Nov; 3(7):436-9. PubMed ID: 12424628
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
16. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
17. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
Brockow K; Jofer C; Behrendt H; Ring J
Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
[TBL] [Abstract][Full Text] [Related]
18. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
19. The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients.
Tsunemi Y; Komine M; Sekiya T; Saeki H; Nakamura K; Hirai K; Kakinuma T; Kagami S; Fujita H; Asano N; Tanida Y; Wakugawa M; Torii H; Tamaki K
Exp Dermatol; 2004 Nov; 13(11):715-9. PubMed ID: 15500644
[TBL] [Abstract][Full Text] [Related]
20. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
